Simcere Pharmaceutical Group Future Growth
Future criteria checks 4/6
Simcere Pharmaceutical Group is forecast to grow earnings and revenue by 24.4% and 14% per annum respectively. EPS is expected to grow by 24.2% per annum. Return on equity is forecast to be 16% in 3 years.
Key information
24.4%
Earnings growth rate
24.2%
EPS growth rate
| Pharmaceuticals earnings growth | 23.7% |
| Revenue growth rate | 14.0% |
| Future return on equity | 16.0% |
| Analyst coverage | Good |
| Last updated | 26 Apr 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 10,103 | 1,542 | 912 | 1,564 | 4 |
| 12/31/2025 | 8,695 | 1,302 | 756 | 1,152 | 6 |
| 12/31/2024 | 7,481 | 1,018 | 751 | 1,375 | 6 |
| 12/31/2023 | 6,608 | 715 | -829 | 151 | N/A |
| 9/30/2023 | 6,806 | 1,928 | -504 | 369 | N/A |
| 6/30/2023 | 6,999 | 3,144 | -178 | 588 | N/A |
| 3/31/2023 | 6,659 | 2,038 | 249 | 971 | N/A |
| 12/31/2022 | 6,324 | 931 | 676 | 1,354 | N/A |
| 9/30/2022 | 5,952 | 972 | 673 | 1,180 | N/A |
| 6/30/2022 | 5,579 | 1,013 | 671 | 1,006 | N/A |
| 3/31/2022 | 5,290 | 1,260 | 130 | 402 | N/A |
| 12/31/2021 | 5,000 | 1,507 | -411 | -202 | N/A |
| 9/30/2021 | 4,852 | 1,274 | -481 | -200 | N/A |
| 6/30/2021 | 4,703 | 1,042 | -551 | -198 | N/A |
| 3/31/2021 | 4,606 | 856 | -404 | -51 | N/A |
| 12/31/2020 | 4,509 | 670 | -256 | 97 | N/A |
| 9/30/2020 | 4,528 | 699 | -314 | -6 | N/A |
| 6/30/2020 | 4,548 | 728 | -371 | -109 | N/A |
| 3/31/2020 | 4,792 | 866 | -53 | 332 | N/A |
| 12/31/2019 | 5,037 | 1,004 | 265 | 773 | N/A |
| 12/31/2018 | 4,514 | 734 | 441 | 776 | N/A |
| 12/31/2017 | 3,868 | 350 | 647 | 939 | N/A |
| 9/30/2013 | 2,027 | 193 | N/A | N/A | N/A |
| 6/30/2013 | 2,111 | 42 | N/A | N/A | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: SMHG.F's forecast earnings growth (24.4% per year) is above the savings rate (2.3%).
Earnings vs Market: SMHG.F's earnings (24.4% per year) are forecast to grow faster than the US market (14.8% per year).
High Growth Earnings: SMHG.F's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: SMHG.F's revenue (14% per year) is forecast to grow faster than the US market (8.2% per year).
High Growth Revenue: SMHG.F's revenue (14% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: SMHG.F's Return on Equity is forecast to be low in 3 years time (16%).